Dear Readers,
In October last year, a significant development unfolded in Vietnam's healthcare sector with the Prime Minister's approval of the National Strategy for the Development of Vietnam's Pharmaceutical Industry up to 2030, and a vision that extends to 2045,
This pivotal strategy, aligning perfectly with Southeast Trading's mission, represents a transformative leap in the nation's healthcare journey.
Accessible Medicines: Ensuring Vietnamese have access to necessary medicines at reasonable prices.
R&D Enhancement: Improving research capacity for original brand-name drugs.
Becoming a Manufacturing Hub: Establishing Vietnam as a regional center for manufacturing, processing, and development of brand-name drugs.
Regulatory System Development: Advancing the pharmaceutical regulatory system to WHO's Maturity Level 4.
High-Quality Herbal Products: Utilizing medicinal herbs and products to develop high-value goods.
Promoting Raw Material Production: Encouraging the production of medicinal raw materials domestically.
Optimizing Medication Use: Focusing on the efficient use of medication.
Ambitious Targets for 2030:
Domestic Drug Production: Aiming for 80% of consumed drugs to be domestically produced.
Vaccine Production: Meeting 100% of expanded vaccination needs.
Original Brand-Name Drugs: Developing at least 100 original brand-name drugs, vaccines, and biological products.
Herbal Medicine Zones: Establishing sustainable exploitation areas for medicinal herbs.
Standardization of Medicinal Ingredients: Ensuring full standardization for domestic drug production.
Achieving WHO Maturity Level 3 or Higher: A stable, well-functioning regulatory system.
100% Compliance: Ensuring all drug establishments and testing facilities meet high standards.
Vision for 2045:
Global Integration: Aiming for the pharmaceutical industry to contribute over $20 billion to GDP by 2045.
Digital Transformation: Complete digitization and deployment of AI in the pharmaceutical industry.
Southeast Trading's Role:
EU-GMP Certification Support: Providing expert consultation to Vietnamese manufacturers to meet EU standards.
Product Registration in Europe: Assisting with navigating the EU's regulatory landscape for market entry.
Distribution Services in Europe: Facilitating entry into the European market, supporting Vietnam's vision of becoming a regional hub.
As we witness this visionary leadership, Southeast Trading is committed to playing a pivotal role in transforming Vietnam's pharmaceutical industry, ensuring global recognition and adherence to international standards.
Stay informed and join us on this transformative journey in healthcare.
Best regards,
Chris Blank Hoàng Trí
Founder, Chairman & CEO, Southeast Trading